Cargando…

Characterization of GECPAR, a noncoding RNA that regulates the transcriptional program of diffuse large B-cell lymphoma

Enhancers are regulatory regions of DNA, which play a key role in cell-type specific differentiation and development. Most active enhancers are transcribed into enhancer RNA (eRNA) that can regulate transcription of target genes by means of in cis as well as in trans action. eRNA stabilize contacts...

Descripción completa

Detalles Bibliográficos
Autores principales:	Napoli, Sara, Cascione, Luciano, Rinaldi, Andrea, Spriano, Filippo, Guidetti, Francesca, Zhang, Fangwen, Cacciapuoti, Maria Teresa, Mensah, Afua Adjeiwaa, Sartori, Giulio, Munz, Nicolas, Forcato, Mattia, Bicciato, Silvio, Chiappella, Annalisa, Ghione, Paola, Elemento, Olivier, Cerchietti, Leandro, Inghirami, Giorgio, Bertoni, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9052922/ https://www.ncbi.nlm.nih.gov/pubmed/34162177 http://dx.doi.org/10.3324/haematol.2020.267096

Ejemplares similares

ASB2 is a direct target of FLI1 that sustains NF-κB pathway activation in germinal center-derived diffuse large B-cell lymphoma
por: Sartori, Giulio, et al.
Publicado: (2021)

Novel HDAC inhibitors exhibit pre-clinical efficacy in lymphoma models and point to the importance of CDKN1A expression levels in mediating their anti-tumor response
por: Mensah, Afua Adjeiwaa, et al.
Publicado: (2014)

Role of ETS1 in the Transcriptional Network of Diffuse Large B Cell Lymphoma of the Activated B Cell-Like Type
por: Priebe, Valdemar, et al.
Publicado: (2020)

Harnessing the Molecular Fingerprints of B Cell Lymphoma for Precision Therapy
por: Mensah, Afua Adjeiwaa, et al.
Publicado: (2022)

BET bromodomain inhibitor birabresib in mantle cell lymphoma: in vivo activity and identification of novel combinations to overcome adaptive resistance
por: Tarantelli, Chiara, et al.
Publicado: (2018)

Resistance to PI3Kδ inhibitors in marginal zone lymphoma can be reverted by targeting the IL-6/PDGFRA axis
por: Arribas, Alberto J., et al.
Publicado: (2022)

Enhancer RNAs (eRNAs) in Cancer: The Jacks of All Trades
por: Napoli, Sara, et al.
Publicado: (2022)

Targeting CD205 with the antibody drug conjugate MEN1309/OBT076 is an active new therapeutic strategy in lymphoma models
por: Gaudio, Eugenio, et al.
Publicado: (2020)

Computational methods for the integrative analysis of single-cell data
por: Forcato, Mattia, et al.
Publicado: (2020)

Exon–Intron Differential Analysis Reveals the Role of Competing Endogenous RNAs in Post-Transcriptional Regulation of Translation
por: Munz, Nicolas, et al.
Publicado: (2021)

Pharmacologic screen identifies active combinations with BET inhibitors and LRRK2 as a novel putative target in lymphoma
por: Spriano, Filippo, et al.
Publicado: (2022)

Epigenomic evolution in diffuse large B-cell lymphomas
por: Pan, Heng, et al.
Publicado: (2015)

Therapeutic efficacy of the bromodomain inhibitor OTX015/MK-8628 in ALK-positive anaplastic large cell lymphoma: an alternative modality to overcome resistant phenotypes
por: Boi, Michela, et al.
Publicado: (2016)

GDA, a web-based tool for Genomics and Drugs integrated analysis
por: Caroli, Jimmy, et al.
Publicado: (2018)

HTGQC and shinyHTGQC: an R package and shinyR application for quality controls of HTG EDGE-seq protocols
por: Terzi di Bergamo, Lodovico, et al.
Publicado: (2022)

Targeting IRAK4 with Emavusertib in Lymphoma Models with Secondary Resistance to PI3K and BTK Inhibitors
por: Guidetti, Francesca, et al.
Publicado: (2023)

Comparison of computational methods for Hi-C data analysis
por: Forcato, Mattia, et al.
Publicado: (2017)

A multifactorial ‘Consensus Signature’ by in silico analysis to predict response to neoadjuvant anthracycline-based chemotherapy in triple-negative breast cancer
por: Turner, Natalie, et al.
Publicado: (2015)

Selective dysregulation of ROCK2 activity promotes aberrant transcriptional networks in ABC diffuse large B-cell lymphoma
por: Ricker, Edd, et al.
Publicado: (2020)

Bromodomain and extra-terminal domain inhibition modulates the expression of pathologically relevant microRNAs in diffuse large B-cell lymphoma
por: Mensah, Afua A., et al.
Publicado: (2018)

T-Cell Leukemia/Lymphoma 1 (TCL1): An Oncogene Regulating Multiple Signaling Pathways
por: Paduano, Francesco, et al.
Publicado: (2018)

IOA-244 is a Non–ATP-competitive, Highly Selective, Tolerable PI3K Delta Inhibitor That Targets Solid Tumors and Breaks Immune Tolerance
por: Johnson, Zoë, et al.
Publicado: (2023)

The Novel TORC1/2 Kinase Inhibitor PQR620 Has Anti-Tumor Activity in Lymphomas as a Single Agent and in Combination with Venetoclax
por: Tarantelli, Chiara, et al.
Publicado: (2019)

Metabolic and Immune Markers for Precise Monitoring of COVID-19 Severity and Treatment
por: Rendeiro, André F., et al.
Publicado: (2022)

Transcriptional profiling of human bronchial epithelial cell BEAS-2B exposed to diesel and biomass ultrafine particles
por: Grilli, Andrea, et al.
Publicado: (2018)

ETV7 regulates breast cancer stem-like cell features by repressing IFN-response genes
por: Pezzè, Laura, et al.
Publicado: (2021)

Long Non-Coding RNAs as Molecular Signatures for Canine B-Cell Lymphoma Characterization
por: Cascione, Luciano, et al.
Publicado: (2019)

AICDA drives epigenetic heterogeneity and accelerates germinal center-derived lymphomagenesis
por: Teater, Matt, et al.
Publicado: (2018)

Are We Ready to Treat Diffuse Large B-cell and High-Grade Lymphoma According to Major Genetic Subtypes?
por: Chiappella, Annalisa, et al.
Publicado: (2019)

Little reason to call them small noncoding RNAs
por: Ferrara, Silvia, et al.
Publicado: (2023)

DNA Copy Number Changes in Diffuse Large B Cell Lymphomas
por: Cascione, Luciano, et al.
Publicado: (2020)

EphB6 Regulates TFEB-Lysosomal Pathway and Survival of Disseminated Indolent Breast Cancer Cells
por: Zangrossi, Manuela, et al.
Publicado: (2021)

The bromodomain and extra-terminal domain degrader MZ1 exhibits preclinical anti-tumoral activity in diffuse large B-cell lymphoma of the activated B cell-like type
por: Tarantelli, Chiara, et al.
Publicado: (2021)

Integration of Bioinformatic Predictions and Experimental Data to Identify circRNA-miRNA Associations
por: Dori, Martina, et al.
Publicado: (2019)

S235: GENERATION AND APPLICATION OF A LIVING T-CELL LYMPHOMA PATIENT-DERIVED TUMOR XENOGRAFT BIOREPOSITORY
por: Cappelli, Luca Vincenzo, et al.
Publicado: (2023)

Hmgb3 Is Regulated by MicroRNA-206 during Muscle Regeneration
por: Maciotta, Simona, et al.
Publicado: (2012)

Glucocorticoid receptor signalling activates YAP in breast cancer
por: Sorrentino, Giovanni, et al.
Publicado: (2017)

ETV7 reduces inflammatory responses in breast cancer cells by repressing the TNFR1/NF-κB axis
por: Meškytė, Erna Marija, et al.
Publicado: (2023)

Stable CDK12 Knock-Out Ovarian Cancer Cells Do Not Show Increased Sensitivity to Cisplatin and PARP Inhibitor Treatment
por: Chilà, Rosaria, et al.
Publicado: (2022)

The calcineurin-NFAT pathway controls activity-dependent circadian gene expression in slow skeletal muscle
por: Dyar, Kenneth A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_aaq5uf85a2karp42v18qg9d4gf